An Observational, Multi-Center, Multi-National, Long Term Follow-Up Study of Atypical Hemolytic Uremic Syndrome (aHUS) Patients Treated With Eculizumab in a Prior Clinical Study
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Eculizumab (Primary)
- Indications Haemolytic uraemic syndrome
- Focus Therapeutic Use
- Acronyms LTFU
- Sponsors Alexion Pharmaceuticals
- 22 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 25 Jul 2016 Planned End Date changed from 1 Sep 2018 to 1 Jan 2017.
- 25 Jul 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2017.